-
What does the novel coronavirus epidemic tell us?
Time of Update: 2020-01-31
China novel coronavirus / xxx January 31, 2020 / BIOON/ is a rapidly studied object of scientists It is good at adapting to new environment and being able to infect new hosts The final result is that
-
New drug for atopic dermatitis! Lilly oral JAK inhibitor olumiant single drug treatment of North America phase III clinical research has been successful!
Time of Update: 2020-01-31
January 30, 2020 / bioun / -- US pharmaceutical giant Eli Lilly and its partner Incyte recently announced that breeze-ad5, a phase III clinical study to evaluate the treatment of moderate to severe at
-
How can we benefit from probiotics?
Time of Update: 2020-01-31
January 31, 2020 / BIOON / -- probiotics is a living microorganism, usually bacteria, which can promote health by being ingested by the body; as early as 100 years ago, researchers found that some mic
-
New anti-inflammatory drugs! Youshibi cimzia has been approved for a variety of psoriasis in Japan and has been listed in China!
Time of Update: 2020-01-31
January 30, 2020 / BIOON / -- UCB, a Belgian pharmaceutical giant, recently announced that the Japanese regulatory authority has approved the approval of cimzia (Chinese trade name: shiminjia ®, gener
-
5 questions about novel coronavirus infection need to be known.
Time of Update: 2020-01-31
January 31, 2020 / BIOON/ China city novel coronavirus novel coronavirus has been isolated from 11 million people in Wuhan and restricted to travel between other cities including Beijing The aim is to
-
Autologous hematopoietic stem cell gene therapy! The US FDA grants otl-102 orphan drug qualification to treat X-linked chronic granulomatosis (X-CGD)!
Time of Update: 2020-01-30
January 29, 2020 / BIOON / -- orchard therapeutics is a new gene therapy company in the UK, which is committed to changing the lives of patients with severe and life-threatening rare diseases through
-
New anti-inflammatory drugs! Sanofi / regenerant dupixent is under priority review in the United States for the treatment of moderate to severe atopic dermatitis in children aged 6-11 years!
Time of Update: 2020-01-29
January 29, 2020 / BIOON/ --Sanofi and Zaihuan announced recently that the US Food and Drug Administration (FDA) has accepted and will give priority to examining a supplementary biological product lic
-
Nature: to reveal the mechanism of cytokine storm induced by catecholamine in immunotherapy
Time of Update: 2020-01-29
January 29, 2020 / Biovalley BIOON / - -- many newly developed powerful cancer therapies aim to utilize immune response targeting tumor However, a common problem of this kind of immunotherapy is the o
-
New drug for atopic dermatitis! Ruxolitinib cream, a Jak1 / 2 inhibitor, has been successfully used in the treatment of critical phase III of adolescent adult patients!
Time of Update: 2020-01-29
January 29, 2020 / Biovalley bio on / -- Incyte company recently published the positive top line results of random, excipient control and critical stage III study (nct03745651) on the evaluation of ru
-
Nat Metab: high protein diet may lead to arterial embolism
Time of Update: 2020-01-28
January 28, 2020 / biogas BIOON / -- a high protein diet can help people lose weight and strengthen muscles, but a new study on mice shows that this diet also has a downside: it can lead to more plaqu
-
New anti-inflammatory drugs! The phase III clinical study on the treatment of atopic dermatitis (AD) with Lilly oral JAK inhibitor olumiant was successful!
Time of Update: 2020-01-28
January 28, 2020 / bioun / -- Eli Lilly, an American pharmaceutical giant, and Incyte, a partner, recently announced that breeze-ad4, a phase III clinical study to evaluate the treatment of moderate t
-
The first treatment for thyroid ophthalmopathy! IGF-1R targeted monoclonal antibody tepezza (teprotumumab) in phase III clinical significantly improved exophthalmos and diplopia!
Time of Update: 2020-01-28
Thyroid ophthalmopathy (TED) (photo source: Mister sign Info) January 28, 2020 / Bio Valley bio on / -- horizon Pharma is a pharmaceutical company focusing on the development and commercialization of
-
Important achievements focus on new progress in the field of virus infection!
Time of Update: 2020-01-27
In this paper, a number of research results have been compiled, focusing on the new progress made by scientists in the field of virus infection research and sharing with you! Source: CDC [1] neuron: i
-
Nature: reveal why about 40% of bacteria lack CRISPR CAS system
Time of Update: 2020-01-27
January 27, 2020 / biool / - -- in a new study, researchers from the University of Exeter in the UK, the University of Montpellier in France and the University of Otago in New Zealand revealed how the
-
Nat commun: new research reveals new mechanism of immune system detection and response to HIV infection
Time of Update: 2020-01-26
January 26, 2020 / Biovalley BIOON / - -- since the introduction of antiretroviral drugs (Art) against HIV infection in 1996, scientists have been keen to find a way to cure the disease Although art d
-
Nature: maternal protective antibody protects newborn from intestinal infection
Time of Update: 2020-01-26
January 23, 2020 / Biovalley BIOON / - -- breast milk has long been considered beneficial to newborns and protects them from certain infections In a new study, researchers from Harvard Medical School
-
PLoS patching: study reveals the mechanism of West Nile virus induced brain inflammation
Time of Update: 2020-01-25
January 26, 2020 / Biovalley / recently, researchers at Hokkaido University found that WNV inhibited autophagy to induce protein aggregation in infected cells, leading to cell death and brain inflamma
-
Brain commin: the immune system actually promotes the spread of brain tumors!
Time of Update: 2020-01-25
January 26, 2020 / BIOON / -- in a study published in the journal Brain communications, a research team led by Carlos barcia, a researcher at the Institute of neuroscience of Barcelona Autonomous Univ
-
Mol ther: study reveals the mechanism of AAV vector entering cells in gene therapy
Time of Update: 2020-01-25
January 26, 2020 / bioun / -- recently, researchers have identified an adeno-associated virus vector (AAV), a new cell entry factor of the most commonly used virus vector for gene therapy in vivo, and
-
Hepatitis B innovative therapy! Geli subcutaneous injection of PD-L1 antibody asc22 was approved by the State Food and drug administration, and clinical trials were carried out in patients with chronic hepatitis B!
Time of Update: 2020-01-24
January 24, 2020 / BIOON / -- ascletis recently announced that its subcutaneous injection of PD-L1 antibody asc22 has been approved by China National Drug Administration (nmpa) to carry out clinical t
